Invaio Sciences Funding: $142M Raised, Series C (2021)
Invaio Sciences is based in Cambridge. It has raised $142M in total funding. Latest round: Series C.
Invaio Sciences funding overview
Invaio Sciences is based in Cambridge. Invaio Sciences has raised $142M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in May 2021. The round record for Invaio Sciences runs through 2021; nothing later has been disclosed. Investors on record include Flagship Pioneering, Stage 1 Ventures, Bluwave Capital, Alexandria Venture Investments. 4 distinct backers are named across the disclosed rounds.
Invaio Sciences has raised $142M in total disclosed funding across the rounds on record.
Who has invested in Invaio Sciences?
Flagship Pioneering, Stage 1 Ventures, Bluwave Capital, Alexandria Venture Investments are named among the investors backing Invaio Sciences.
What was the latest Invaio Sciences funding round?
The most recent disclosed round is a Series C, announced in May 2021.
Where is Invaio Sciences based?
Invaio Sciences is based in Cambridge.
When did Invaio Sciences last raise?
The last disclosed Invaio Sciences round closed in May 2021 at Series C.
Totals shown for Invaio Sciences aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
